Details for Patent: 6,936,590
✉ Email this page to a colleague
Summary for Patent: 6,936,590
Title: | C-aryl glucoside SGLT2 inhibitors and method |
Abstract: | A method is provided for treating diabetes and related diseases employing an SGLT2 inhibiting amount of a compound of the formula ##STR1## alone or in combination with one or more other antidiabetic agent(s) or other therapeutic agent(s). |
Inventor(s): | Washburn; William N. (Titusville, NJ), Ellsworth; Bruce (Princeton, NJ), Meng; Wei (Pennington, NJ), Wu; Gang (Princeton, NJ), Sher; Philip M. (Plainsboro, NJ) |
Assignee: | Bristol Myers Squibb Company (Princeton, NJ) |
Application Number: | 10/264,410 |
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 6,936,590
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |